Non-Adherence to Antidepressant Treatment and Related Factors in a Region of Spain: A Population-Based Registry Study
Open accessThe DOI matches its Crossref record; 68 of the 68 references it cites were found in a registry or an index.
Abstract
Antidepressants are a commonly prescribed psychotropic medication, and their use has increased in recent years. Medication non-adherence in patients with mental disorders is associated with worse health outcomes. A population-based registry study to assess antidepressant non-adherence during 2021 has been carried out. An indirect method based on the medication possession ratio (MPR) has been utilized. Patients with a MPR under 80% were classified as non-adherent. A multivariate logistic regression to identify non-adherence predictors has been used, considering sociodemographic (age, sex, institutionalization and urbanicity) and health related variables (diagnostics, antidepressant class, multiple prescribers, and polypharmacy). In 2021, 10.6% of the Castile and Leon population used antidepressants. These patients were institutionalized (7.29%), living in urban areas (63.44%), polymedicated with multiple prescribers (57.07%), and using serotonin selective reuptake inhibitors (SSRIs) (54.77%), other antidepressants (46.82%) or tricyclic antidepressants (TCAs) (13.76%). Antidepressants were prescribed mainly for depression (36.73%) and anxiety (29.24%). Non-adherence to antidepressants was more frequent in men (20.56%) than in woman (19.59%) and decreased with increasing age (32% up to 17 years old vs. 13.76% over 80 years old). TCAs were associated with the highest prevalence of non-adherence (23.99%), followed by SSRIs (20.19%) and other antidepressants (18.5%). Predictors of non-adherence in patients on antidepressants were: living in urban areas, using TCAs, and pain occurrence. Non-adherence to antidepressants decreases with aging. Being female, institutionalization, being polymedicated and having depression/anxiety alongside another psychiatric diagnosis are protective factors against non-adherence. The MPR is a robust indicator for the clinician to identify non-adherent patients for monitoring, and adopt any necessary corrective actions.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Using this definition, about 30- 50% of persons prescribed with antidepressants are non- adherent in acute phase treatment 169 .”
From Treatment‐resistant depression: definition, prevalence, detection, management, and investigational interventions (2023) · cites this paper as [169]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“A replicated observation is the high rate of non- adherence to antidepressants in persons with MDD.”
From Treatment‐resistant depression: definition, prevalence, detection, management, and investigational interventions (2023) · cites this paper as [169]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
von Elm, E., Altman, D. G., Egger, M., Pocock, S. J., Gøtzsche, P. C., Vandenbroucke, J. P., & Initiative, F. T. S. (2007) · PLoS Medicine · doi:10.1371/journal.pmed.0040296 · Cited by 23,020
von Elm, E., Altman, D. G., Egger, M., Pocock, S. J., Gøtzsche, P. C., & Vandenbroucke, J. P. (2008) · Journal of Clinical Epidemiology · doi:10.1016/j.jclinepi.2007.11.008 · Cited by 17,893
Osterberg, L., & Blaschke, T. (2005) · New England Journal of Medicine · doi:10.1056/nejmra050100 · Cited by 7,974
Benchimol, E. I., Smeeth, L., Guttmann, A., Harron, K., Moher, D., Petersen, I., Sørensen, H. T., von Elm, E., Langan, S. M., & RECORD Working Committee (2015) · PLOS Medicine · doi:10.1371/journal.pmed.1001885 · Cited by 5,749
Santomauro, D. F., Mantilla Herrera, A. M., Shadid, J., Zheng, P., Ashbaugh, C., Pigott, D. M., Abbafati, C., Adolph, C., Amlag, J. O., Aravkin, A. Y., et al. (2021) · The Lancet · doi:10.1016/s0140-6736(21)02143-7 · Cited by 5,444
Kirk, J., MacDonald, A., Lavender, P., Dean, J., & Rubin, G. (2017) · Biomedicine Hub · doi:10.1159/000480347 · Cited by 3,887
Methods for evaluation of medication adherence and persistence using automated databases
Andrade, S. E., Kahler, K. H., Frech, F., & Chan, K. A. (2006) · Pharmacoepidemiology and Drug Safety · doi:10.1002/pds.1230 · Cited by 1,079
Economic impact of medication non-adherence by disease groups: a systematic review
Cutler, R. L., Fernandez-Llimos, F., Frommer, M., Benrimoj, C., & Garcia-Cardenas, V. (2018) · BMJ Open · doi:10.1136/bmjopen-2017-016982 · Cited by 900
Mirowsky, J., & Ross, C. E. (1992) · Journal of Health and Social Behavior · doi:10.2307/2137349 · Cited by 837
Determinants of patient adherence: a review of systematic reviews
Kardas, P., Lewek, P., & Matyjaszczyk, M. (2013) · Frontiers in Pharmacology · doi:10.3389/fphar.2013.00091 · Cited by 809 · cited 1×
“This factor is of high importance since the increase in prescribed medications and the regimen complexity is associated with lower medication adherence [62].”
BackgroundUrbanization, Urbanicity, and Health
Vlahov, D. (2002) · Journal of Urban Health: Bulletin of the New York Academy of Medicine · doi:10.1093/jurban/79.suppl_1.s1 · Cited by 555
Semahegn, A., Torpey, K., Manu, A., Assefa, N., Tesfaye, G., & Ankomah, A. (2020) · Systematic Reviews · doi:10.1186/s13643-020-1274-3 · Cited by 555
Patient adherence in the treatment of depression
Pampallona, S., Bollini, P., Tibaldi, G., Kupelnick, B., & Munizza, C. (2002) · British Journal of Psychiatry · doi:10.1192/bjp.180.2.104 · Cited by 292
Medication Adherence to Multidrug Regimens
Marcum, Z. A., & Gellad, W. F. (2012) · Clinics in Geriatric Medicine · doi:10.1016/j.cger.2012.01.008 · Cited by 264
A Systematic Review of Medication Adherence Thresholds Dependent of Clinical Outcomes
Baumgartner, P. C., Haynes, R. B., Hersberger, K. E., & Arnet, I. (2018) · Frontiers in Pharmacology · doi:10.3389/fphar.2018.01290 · Cited by 255
Helfer, B., Samara, M. T., Huhn, M., Klupp, E., Leucht, C., Zhu, Y., Engel, R. R., & Leucht, S. (2016) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2016.15081035 · Cited by 246
From Morisky to Hill-bone; self-reports scales for measuring adherence to medication.
Javorić, H., Topolovec-Nižetić, V., & Pavleković, G. (2014) · PubMed · Cited by 219
Antidepressant adherence: are patients taking their medications?
Sansone, R. A., & Sansone, L. A. (2012) · Europe PMC (PubMed Central) · Cited by 208
Psychotropic medicine consumption in 65 countries and regions, 2008-19: A longitudinal study
Brauer, R., Alfageh, B., Blais, J. E., Chan, E. W., Chui, C. S. L., Hayes, J. F., Man, K. K. C., Lau, W. C. Y., Yan, V. K. C., Beykloo, M. Y., et al. (2021) · The Lancet Psychiatry · doi:10.1016/s2215-0366(21)00292-3 · Cited by 203
Métodos para medir la adherencia terapeútica
Pagès‐Puigdemont, N., & Valverde-Merino, M. I. (2018) · Ars Pharmaceutica (Internet) · doi:10.30827/ars.v59i3.7387 · Cited by 201
Evidence-Based Strategies for the Optimization of Pharmacotherapy in Older People
Topinková, E., Baeyens, J., Michel, J., & Lang, P. O. (2012) · Drugs & Aging · doi:10.2165/11632400-000000000-00000 · Cited by 195
Pharmacological treatment of unipolar depressive disorders: summary of WFSBP guidelines
Bauer, M., Severus, E., Möller, H.-J., Young, A. H., & WFSBP Task Force on Unipolar Depressive Disorders (2017) · International Journal of Psychiatry in Clinical Practice · doi:10.1080/13651501.2017.1306082 · Cited by 175
Green, J. L., Hawley, J. N., & Rask, K. J. (2007) · The American Journal of Geriatric Pharmacotherapy · doi:10.1016/j.amjopharm.2007.03.004 · Cited by 160
Mirowsky, J., & Ross, C. E. (1992) · PubMed · Cited by 117
Steiner, J. F. (2012) · Annals of Internal Medicine · doi:10.7326/0003-4819-157-8-201210160-00013 · Cited by 104
Keyloun, K. R., Hansen, R. N., Hepp, Z., Gillard, P., Thase, M. E., & Devine, E. B. (2017) · CNS Drugs · doi:10.1007/s40263-017-0417-0 · Cited by 99 · cited 1×
“A study assessing adherence and persistence to antidepressants, focused on patients with a major depressive disorder, stated that those on serotonin and norepinephrine reuptake inhibitors (SNRI), included in “other antidepressants” class, were more likely than those on SSRIs to carry on taking the drug over the period…”
BackgroundAdherence to continuation and maintenance antidepressant use in recurrent depression
ten Doesschate, M. C., Bockting, C. L. H., & Schene, A. H. (2009) · Journal of Affective Disorders · doi:10.1016/j.jad.2008.07.011 · Cited by 86
Adherencia terapéutica en la enfermedad crónica: estado de la situación y perspectiva de futuro
Conthe, P., Contreras, E. M., Pérez, A. A., García, B., Martín, M. N. F. D. C., Jurado, M. A. G., Baturone, M. O., & Pinto, J. L. (2014) · Revista Clínica Española · doi:10.1016/j.rce.2014.03.008 · Cited by 85
Factors Associated with Antidepressant Medication Non-adherence
Marasine, N. R., & Sankhi, S. (2021) · Turkish Journal of Pharmaceutical Sciences · doi:10.4274/tjps.galenos.2020.49799 · Cited by 83
Deng, M., Zhai, S., Ouyang, X., Liu, Z., & Ross, B. (2022) · BMC Psychiatry · doi:10.1186/s12888-021-03681-6 · Cited by 75
Prescriber Continuity and Medication Adherence for Complex Patients
Hansen, R. A., Voils, C. I., Farley, J. F., Powers, B. J., Sanders, L. L., Sleath, B. L., & Maciejewski, M. L. (2014) · Annals of Pharmacotherapy · doi:10.1177/1060028014563266 · Cited by 73
Perestelo-Perez, L., Perestelo-Perez, Perez-Ramos, Serrano-Aguilar, & Cuevas, D. L. (2013) · Patient Preference and Adherence · doi:10.2147/ppa.s39382 · Cited by 54
The impact of age and gender on adherence to antidepressants: a 4-year population-based cohort study
Krivoy, A., Balicer, R. D., Feldman, B., Hoshen, M., Zalsman, G., Weizman, A., & Shoval, G. (2015) · Psychopharmacology · doi:10.1007/s00213-015-3988-9 · Cited by 52
Holvast, F., Voshaar, R. C. O., Wouters, H., Hek, K., Schellevis, F., Burger, H., & Verhaak, P. F. M. (2018) · Family Practice · doi:10.1093/fampra/cmy106 · Cited by 46
Chen, S., Ford, T. J., Jones, P. B., & Cardinal, R. N. (2022) · The Lancet Regional Health - Europe · doi:10.1016/j.lanepe.2022.100368 · Cited by 42
Krivoy, A., Balicer, R. D., Feldman, B., Hoshen, M., Zalsman, G., Weizman, A., & Shoval, G. (2016) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.14m09531 · Cited by 41
Determinants of suboptimal medication adherence in patients with a major depressive episode
Baeza‐Velasco, C., Olié, É., Béziat, S., Guillaume, S., & Courtet, P. (2018) · Depression and Anxiety · doi:10.1002/da.22852 · Cited by 41
Bramesfeld, A., Grobe, T., & Schwartz, F. W. (2009) · Social Psychiatry and Psychiatric Epidemiology · doi:10.1007/s00127-009-0067-8 · Cited by 40
van Servellen, G. M., Heise, B. A., & Ellis, R. (2011) · Europe PMC (PubMed Central) · Cited by 38
Treatment compliance in chronic illness: Current situation and future perspectives
Conthe, P., Contreras, E. M., Pérez, A. A., García, B., Martín, M. N. F. D. C., Jurado, M. A. G., Baturone, M. O., & Pinto, J. L. (2014) · Revista Clínica Española (English Edition) · doi:10.1016/j.rceng.2014.03.003 · Cited by 38
Green, I., Stow, D., Matthews, F. E., & Hanratty, B. (2017) · Age and Ageing · doi:10.1093/ageing/afx046 · Cited by 38
Seguimiento de la adherencia al tratamiento antidepresivo en pacientes que inician su consumo
Martínez, I. P., Hidalgo, J. D. L.-T., Campo, J. M. D. C.-D., Ferrer, A. V., Rayo, S. M., & Rabadán, F. E. (2014) · Atención Primaria · doi:10.1016/j.aprim.2013.11.003 · Cited by 37
Evaluating Factors Impacting Medication Adherence Among Rural, Urban, and Suburban Populations
Arbuckle, C., Tomaszewski, D., Aronson, B. D., Brown, L. M., Schommer, J. C., Morisky, D. E., & Linstead, E. J. (2018) · The Journal of Rural Health · doi:10.1111/jrh.12291 · Cited by 34
Serna, M. C., Real, J., Cruz, I., Galván, L., & Martin, E. (2015) · BMC Public Health · doi:10.1186/s12889-015-2493-8 · Cited by 32
Agomelatine-induced hepatotoxicity
Štuhec, M. (2013) · Wiener klinische Wochenschrift · doi:10.1007/s00508-013-0344-0 · Cited by 26
Korean Medication Algorithm for Depressive Disorder: Comparisons with Other Treatment Guidelines
Wang, H. R., Bahk, W., Seo, J. S., Woo, Y. S., Park, Y., Jeong, J., Kim, W. K., Shim, S.-H., Lee, J. G., Jon, D., et al. (2017) · Clinical Psychopharmacology and Neuroscience · doi:10.9758/cpn.2017.15.3.199 · Cited by 24
Ta, J. T., Sullivan, S. D., Tung, A., Oliveri, D., Gillard, P. J., & Devine, B. (2021) · Journal of Managed Care & Specialty Pharmacy · doi:10.18553/jmcp.2021.27.2.223 · Cited by 24
Use of driving-impairing medicines by a Spanish population: a population-based registry study
Gutiérrez‐Abejón, E., Herrera‐Gómez, F., Criado-Espegel, P., & Alvarez, E. (2017) · BMJ Open · doi:10.1136/bmjopen-2017-017618 · Cited by 23
Self-citationMedication adherence and measures of health plan quality.
Seabury, S. A., Lakdawalla, D., Dougherty, J. S., Sullivan, J., & Goldman, D. P. (2015) · PubMed · Cited by 22
Herrera‐Gómez, F., Gutiérrez‐Abejón, E., Criado-Espegel, P., & Alvarez, E. (2018) · Frontiers in Pharmacology · doi:10.3389/fphar.2018.00408 · Cited by 22
Self-citationRate of non-adherence prior to upward dose titration in previously stable antidepressant users
Muzina, D. J., Malone, D. A., Bhandari, I., Lulic, R., Baudisch, R., & Keene, M. (2010) · Journal of Affective Disorders · doi:10.1016/j.jad.2010.09.018 · Cited by 21
Gutiérrez‐Abejón, E., Herrera‐Gómez, F., Criado-Espegel, P., & Alvarez, E. (2020) · Pharmaceuticals · doi:10.3390/ph13040061 · Cited by 20
Self-citationPrieto-Vila, M., Estupiñá, F. J., & Vindel, A. C. (2021) · Psicothema · doi:10.7334/psicothema2020.186 · Cited by 20
AlGameel, M. (2020) · Pakistan Journal of Medical Sciences · doi:10.12669/pjms.36.4.1923 · Cited by 18 · cited 1×
“The other one could be due to the fact that a minority of institutionalized patients still manage their medication on their own, and are not closely supervised on this issue [54].”
BackgroundIlić, D., Bukumirić, Z., & Јаnkovic, S. (2015) · Srpski arhiv za celokupno lekarstvo · doi:10.2298/sarh1504174i · Cited by 17
Geosocial Factors Associated With Adherence to Statin Medications
Erickson, S. R., Bravo, M. A., & Tootoo, J. L. (2020) · Annals of Pharmacotherapy · doi:10.1177/1060028020934879 · Cited by 15
Herrera‐Gómez, F., Gutiérrez‐Abejón, E., Ayestarán, I., Criado-Espegel, P., & Alvarez, E. (2019) · Journal of Clinical Medicine · doi:10.3390/jcm8122148 · Cited by 14
Self-citationEffects of an integrated care program for outpatients with affective or psychotic disorders
Hamann, J., Heres, S., Seemann, U., Beitinger, R., Spill, B., & Kissling, W. (2014) · Psychiatry Research · doi:10.1016/j.psychres.2014.02.005 · Cited by 13
Herrera‐Gómez, F., Gutiérrez‐Abejón, E., & Alvarez, E. (2019) · International Clinical Psychopharmacology · doi:10.1097/yic.0000000000000263 · Cited by 10
Self-citationBordson, S. J., Atayee, R. S., JOSEPH, D. R., & Best, B. M. (2014) · Pain Medicine · doi:10.1111/pme.12300 · Cited by 9
Gutiérrez‐Abejón, E., Herrera‐Gómez, F., & Álvarez, F. J. (2021) · Fundamental and Clinical Pharmacology · doi:10.1111/fcp.12680 · Cited by 9
Self-citationAdherence to and Persistence with Adalimumab Therapy among Swedish Patients with Crohn’s Disease
Liu, Y., Söderberg, J., & Chao, J. (2022) · Pharmacy · doi:10.3390/pharmacy10040087 · Cited by 9
Ingemann, T. N., Backe, M. B., Bonefeld‐Jørgensen, E. C., Skovgaard, N., & Pedersen, M. L. (2021) · International Journal of Circumpolar Health · doi:10.1080/22423982.2021.1912540 · Cited by 8
Wong, J., Kurteva, S., Motulsky, A., & Tamblyn, R. (2021) · Medical Care · doi:10.1097/mlr.0000000000001658 · Cited by 8
Alnijadi, A. A., Yuan, J., Wu, J., Li, M., & Lu, K. (2021) · Frontiers in Pharmacology · doi:10.3389/fphar.2021.764697 · Cited by 7
Gutiérrez‐Abejón, E., Criado-Espegel, P., Herrera‐Gómez, F., & Alvarez, E. (2020) · Pharmaceuticals · doi:10.3390/ph13080165 · Cited by 5
Self-citationProsser, T. R., & Bollmeier, S. G. (2022) · Journal of the American Pharmacists Association · doi:10.1016/j.japh.2022.02.011 · Cited by 3
Cited by
McIntyre, R. S., Alsuwaidan, M., Baune, B. T., Berk, M., Demyttenaere, K., Goldberg, J. F., Gorwood, P., Ho, R., Kasper, S., Kennedy, S. H., et al. (2023) · World Psychiatry · doi:10.1002/wps.21120 · Cited by 836
Zewdu, W. S., Dagnew, S. B., Tarekegn, G. Y., Yazie, T. S., Ayicheh, M. A., Dagnew, F. N., & Moges, T. A. (2025) · BMC Psychiatry · doi:10.1186/s12888-025-06838-9 · Cited by 23
Ishtiak‐Ahmed, K., Köhler‐Forsberg, O., Mortensen, E. L., Nierenberg, A. A., & Gasse, C. (2023) · Drugs & Aging · doi:10.1007/s40266-023-01018-4 · Cited by 17
Muhammad, N., Ullah, S. R., Nagi, T. K., & Yousaf, R. A. (2023) · Cureus · doi:10.7759/cureus.37828 · Cited by 16
del Pino‐Sedeño, T., González‐Pacheco, H., de León, B. G., Serrano-Pérez, P., Acosta, F. J., Valcárcel‐Nazco, C., Hurtado, I., Álvarez, C. R., Trujillo‐Martín, M. M., & on behalf of MAPDep Team (2024) · Frontiers in Public Health · doi:10.3389/fpubh.2024.1320159 · Cited by 13
Metadata
- Authors
- Pedrosa-Naudín, M. A., Gutiérrez-Abejón, E., Herrera-Gómez, F., Fernández-Lázaro, D., & Álvarez, F. J.
- Affiliations
- Gerencia Regional de Salud de Castilla y León (Sacyl) (ES)
- Pharmacy Directorate, Castilla y León Health Council, 47007 Valladolid, Spain
- Pharmacological Big Data Laboratory, Faculty of Medicine, University of Valladolid, 47005 Valladolid, Spain
- Department of Cellular Biology, Histology and Pharmacology, Faculty of Health Sciences, Campus of Soria, University of Valladolid, 42003 Soria, Spain
- ORCID
- Venue
- Pharmaceutics
- Publisher
- MDPI AG
- Published
- 2022-12-02
- Volume
- 14
- Issue
- 12
- Pages
- 2696
- ISSN
- 1999-4923 (ISSN-L)
- PMC
- PMC9782667
- OpenAlex
- W4311098684
- Cited by
- 31
- References
- 67
- Citations by year
- 2026: 9 · 2025: 11 · 2024: 4 · 2023: 7
- FWCI
- 5.89
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- Pharmaceutics (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Hispana (publishedVersion, cc-by)
- SERVAL (Université de Lausanne) (publishedVersion, cc-by)
- IRIS (submittedVersion, cc-by)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- UVaDOC UVaDOC University of Valladolid Documentary Repository (University of Valladolid) (submittedVersion, cc-by)
- Funders
- Instituto de Salud Carlos III, Redes Temáticas de Investigación Cooperativa, Red de Trastornos Adictivos (RD16/0017/0006)
- the European Regional Development Fund (ERDF) (RD16/0017/0006)
- Topics
- Health Sciences › Medicine › Family Practice › Medication Adherence and Compliance
- Health Sciences › Medicine › Psychiatry and Mental health › Mental Health Treatment and Access
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Opioid Use Disorder Treatment
- Keywords
- medication possession ratio, antidepressants, tricyclic antidepressants, selective serotonin reuptake inhibitors, polypharmacy, multiple prescribers, depression, anxiety, institutionalization, urbanicity, age differences, sex differences, pain, Castilla y León
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.
